UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT
TO § 240.13d-1(b), (c), AND (d)
AND AMENDMENTS THERETO FILED
PURSUANT TO § 240.13d-2
(Amendment No. 1)*
Intrexon
Corporation
|
(Name
of Issuer)
|
|
Common
Stock
|
(Title
of Class of Securities)
|
|
46122T102
|
(CUSIP
Number)
|
|
31
December 2019
|
(Date
of Event Which Requires Filing of the Statement)
|
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act
of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
Cusip
No. 46122T102
|
13G
|
Page
2 of 8 Pages
|
1.
|
NAME OF REPORTING PERSONS
Ares Trading SA
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see
instructions)
(a)
o
(b)
o
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5.
|
SOLE VOTING POWER
24,852,3481
|
6.
|
SHARED VOTING POWER
0
|
7.
|
SOLE DISPOSITIVE POWER
24,852,3481
|
8.
|
SHARED DISPOSITIVE POWER
0
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
24,852,3481
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
o
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
14.9%2
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
1
|
The
record holder of the securities covered by this Schedule 13G is Ares Trading SA.
|
Ares
Trading SA is a dominantly controlled subsidiary of Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt,
Germany.
Merck
Serono SA, Coinsins, Switzerland is a wholly owned indirect subsidiary of Merck KGaA, Darmstadt, Germany.
Merck
KGaA, Darmstadt, Germany is a publicly traded company (Frankfurt Stock Exchange, DAX 30) and the beneficiary of the two companies.
Merck
Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany and Merck KGaA, Darmstadt, Germany may be deemed
to possess sole voting and dispositive power with respect to the securities held of record by Ares Trading SA.
2 This percentage is
based upon a denominator that is the sum of: (a) 162,682,637 shares of Common Stock outstanding as reported in the Issuer’s
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019 and (b) 4,212,229 shares
of Common Stock that may be acquired upon the conversion of a certain Convertible Note held by the Reporting Persons, assuming
full conversion of the Convertible Note at an assumed conversion price of $5.9351 per share as of December 31, 2019.
Cusip
No. 46122T102
|
13G
|
Page
3 of 8 Pages
|
1.
|
NAME OF REPORTING PERSONS
Merck Serono SA, Coinsins, Switzerland, an affiliate
of Merck KGaA, Darmstadt, Germany
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see
instructions)
(a)
o
(b)
o
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5.
|
SOLE VOTING POWER
24,852,3483
|
6.
|
SHARED VOTING POWER
0
|
7.
|
SOLE DISPOSITIVE POWER
24,852,3483
|
8.
|
SHARED DISPOSITIVE POWER
0
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
24,852,3483
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
o
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
14.9%4
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
3
|
The
record holder of the securities covered by this Schedule 13G is Ares Trading SA.
|
Ares
Trading SA is a dominantly controlled subsidiary of Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt,
Germany.
Merck
Serono SA, Coinsins, Switzerland is a wholly owned indirect subsidiary of Merck KGaA, Darmstadt, Germany.
Merck
KGaA, Darmstadt, Germany is a publicly traded company (Frankfurt Stock Exchange, DAX 30) and the beneficiary of the two companies.
Merck
Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany and Merck KGaA, Darmstadt, Germany may be deemed
to possess sole voting and dispositive power with respect to the securities held of record by Ares Trading SA.
4 This percentage is
based upon a denominator that is the sum of: (a) 162,682,637 shares of Common Stock outstanding as reported in the Issuer’s
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019 and (b) 4,212,229 shares
of Common Stock that may be acquired upon the conversion of a certain Convertible Note held by the Reporting Persons, assuming
full conversion of the Convertible Note at an assumed conversion price of $5.9351 per share as of December 31, 2019.
Cusip
No. 46122T102
|
13G
|
Page
4 of 8 Pages
|
1.
|
NAME OF REPORTING PERSONS
Merck KGaA, Darmstadt, Germany
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see
instructions)
(a)
o
(b)
o
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5.
|
SOLE VOTING POWER
24,852,3485
|
6.
|
SHARED VOTING POWER
0
|
7.
|
SOLE DISPOSITIVE POWER
24,852,3485
|
8.
|
SHARED DISPOSITIVE POWER
0
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
24,852,3485
|
10.
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
o
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
14.9%6
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
|
5
|
The
record holder of the securities covered by this Schedule 13G is Ares Trading SA.
|
Ares
Trading SA is a dominantly controlled subsidiary of Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt,
Germany.
Merck
Serono SA, Coinsins, Switzerland is a wholly owned indirect subsidiary of Merck KGaA, Darmstadt, Germany.
Merck
KGaA, Darmstadt, Germany is a publicly traded company (Frankfurt Stock Exchange, DAX 30) and the beneficiary of the two companies.
Merck
Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany and Merck KGaA, Darmstadt, Germany may be deemed
to possess sole voting and dispositive power with respect to the securities held of record by Ares Trading SA
6 This percentage is
based upon a denominator that is the sum of: (a) 162,682,637 shares of Common Stock outstanding as reported in the Issuer’s
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019 and (b) 4,212,229 shares
of Common Stock that may be acquired upon the conversion of a certain Convertible Note held by the Reporting Persons, assuming
full conversion of the Convertible Note at an assumed conversion price of $5.9351 per share as of December 31, 2019.
Cusip
No. 46122T102
|
13G
|
Page
5 of 8 Pages
|
Item 1(a).
|
Name
of Issuer:
|
|
Intrexon
Corporation
|
|
|
Item 1(b).
|
Address
of Issuer’s Principal Executive Offices:
|
|
20374 Seneca
Meadows Parkway
|
|
Germantown,
Maryland, 20876
|
Item 2(a).
|
Name
of Person Filing:
|
|
This Schedule 13G is being filed by each of the following
persons (each, a “Reporting Person” and together, the “Reporting Persons”):
Ares Trading SA
Merck Serono SA, Coinsins, Switzerland, an affiliate
of Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
The Reporting Persons have entered into a Joint Filing
Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which the Reporting Persons have
agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k)(l) of the Securities Exchange
Act of 1934, as amended.
|
|
|
Item 2(b).
|
Address
of Principal Business Office or, if none, Residence:
|
|
Ares Trading SA: Zone Industrielle de l’Outriettaz,
1170 Aubonne, Switzerland
Merck Serono SA: Zone Industrielle, 1267 Coinsins,
Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany
Merck KGaA: Frankfurter Strasse 250, 64293 Darmstadt,
Germany
|
|
|
Item 2(c).
|
Citizenship:
|
|
The Reporting
Persons Ares Trading SA and Merck Serono SA Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany are organized
in Switzerland. The Reporting Person Merck KGaA is organized in Darmstadt, Germany.
|
|
|
Item 2(d).
|
Title
of Class of Securities:
|
|
Common Stock,
no par value per share
|
|
|
Item 2(e).
|
CUSIP
Number:
|
|
46122T102
|
|
|
Item
3.
|
If
this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is
a:
|
|
Not applicable
|
|
(a)
|
o
|
Broker
or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
|
|
(b)
|
o
|
Bank
as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
|
|
(c)
|
o
|
Insurance
company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
|
|
(d)
|
o
|
Investment
company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
|
(e)
|
o
|
An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
o
|
An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
o
|
A
parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
o
|
A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
o
|
A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act (15 U.S.C. 80a-3);
|
|
(j)
|
o
|
A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
|
|
(k)
|
o
|
Group,
in accordance with § 240.13d-1(b)(1)(ii)(K).
|
Cusip
No. 46122T102
|
13G
|
Page
6 of 8 Pages
|
Item
4.
|
Ownership:
|
|
Provide
the following information regarding the aggregate number and percentage of the class of securities of the issuer identified
in Item 1.
|
(a)
|
Amount beneficially
owned: 24,852,3487
|
|
|
(b)
|
Percent of class:
14.9%8
|
|
|
(c)
|
Number of shares
as to which the person has:
|
|
|
|
(i)
|
Sole
power to vote or to direct the vote: 20,640,1197
|
|
(ii)
|
Shared
power to vote or to direct the vote: 0
|
|
(iii)
|
Sole
power to dispose or to direct the disposition of: 20,640,1197
|
|
(iv)
|
Shared
power to dispose or to direct the disposition of: 0
|
Item
5.
|
Ownership of
Five Percent or Less of a Class:
|
|
If this statement
is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than 5 percent of the class of securities, check the following o.
|
|
|
Item 6.
|
Ownership of
More Than Five Percent on Behalf of Another Person:
|
|
Not applicable
|
Item 7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
|
|
Not applicable
|
Item 8.
|
Identification
and Classification of Members of the Group:
|
|
Not applicable
|
Item 9.
|
Notice of Dissolution
of Group:
|
|
Not applicable
|
Item 10.
|
Certifications:
|
|
By signing below
I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than
activities solely in connection with a nomination under § 240.14a-11.
|
|
7
|
The
record holder of the securities covered by this Schedule 13G is Ares Trading SA.
|
Ares
Trading SA is a dominantly controlled subsidiary of Merck Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt,
Germany.
Merck
Serono SA, Coinsins, Switzerland is a wholly owned indirect subsidiary of Merck KGaA, Darmstadt, Germany.
Merck
KGaA, Darmstadt, Germany is a publicly traded company (Frankfurt Stock Exchange, DAX 30) and the beneficiary of the two companies.
Merck
Serono SA, Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany and Merck KGaA, Darmstadt, Germany may be deemed
to possess sole voting and dispositive power with respect to the securities held of record by Ares Trading SA.
In
addition to 20,640,119 shares of Common Stock, Ares Trading SA holds a Convertible Note in the original principal amount of $25,000,000
issued pursuant to a certain Securities Purchase, Assignment and Assumption Agreement, dated as of December 19, 2018, by and among
the Issuer, Ares Trading SA and Precigen, Inc., as reported in the Issuer’s Current Reports on Form 8-K filed with the Securities
and Exchange Commission on December 20, 2018 and December 31, 2018. The Convertible Note matures on June 28, 2021 and is convertible
at any time into Common Stock of the Issuer in minimum increments of $5,000,000, subject to limited exceptions. The Convertible
Note may also be converted into common stock or other equity securities of Precigen, Inc. in the event of certain qualified financings
by Precigen, Inc. Any outstanding principal amount under the Convertible Note will automatically convert into shares of Common
Stock on the first trading day following the date that is the second anniversary of the issuance of the Convertible Note. The
conversion price of the Convertible Note, assuming conversion into Common Stock, will be equal to (a) the volume weighted-average
price per share of the Common Stock on the Nasdaq Stock Market for the consecutive ten trading days immediately prior to the conversion
date as reported by Bloomberg, L.P. or (b) if converted in connection with a qualified public offering by the Issuer, the lowest
price per share of Common Stock paid by a purchaser in such qualified public offering.
The
amount of securities reported as beneficially owned by the Reporting Persons includes 4,212,229 shares of Common Stock which may
be acquired by the Reporting Persons within 60 days of the date hereof, based on the assumed conversion in full of the Convertible
Note at a conversion price of $5.9351 per share.
In
the event the aggregate shares of Common Stock issued or issuable to the Reporting Persons pursuant to the Purchase Agreement
exceeds 19.99% of the outstanding shares of Common Stock as of the date of the Purchase Agreement, the Issuer has agreed to seek
shareholder approval for the issuance of the shares of Common Stock in excess of such threshold. If the Issuer is unable to obtain
such shareholder consent, Ares Trading SA will be entitled to receive an amount in cash equal to the value of the shares of Common
Stock that would have been issuable upon conversion of the Convertible Note, but for such limitation.
8 This
percentage is based upon a denominator that is the sum of: (a) 162,682,637 shares of Common Stock outstanding as reported in the
Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2019 and (b) 4,212,229
shares of Common Stock that may be acquired upon the conversion of a certain Convertible Note held by the Reporting Persons, assuming
full conversion of the Convertible Note at an assumed conversion price of $5.9351 per share as of December 31, 2019.
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
ARES TRADING SA
|
|
ARES TRADING SA
|
|
Date:
|
January
20, 2020
|
|
Date:
|
January
20, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Cedric Hyde
|
|
By:
|
/s/ Florence Jolidon
|
|
|
|
|
|
|
|
Name:
|
Cedric
Hyde
|
|
Name:
|
Florence Jolidon
|
|
|
|
|
|
|
|
Title:
|
CFO
|
|
Title:
|
Finance Manager
|
|
MERCK SERONO SA, COINSINS, SWITZERLAND,
AN AFFILIATE OF MERCK KGAA, DARMSTADT, GERMANY
|
|
MERCK SERONO SA, COINSINS, SWITZERLAND, AN AFFILIATE
OF MERCK KGAA, DARMSTADT, GERMANY
|
|
Date:
|
January
20, 2020
|
|
Date:
|
January
20, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
Cecric Hyde
|
|
By:
|
/s/ Tearaboth Te
|
|
|
|
|
|
|
|
Name:
|
Cedric
Hyde
|
|
Name:
|
Tearaboth
Te
|
|
|
|
|
|
|
|
Title:
|
CFO
|
|
Title:
|
Treasury
Director
|
|
MERCK KGAA, DARMSTADT, GERMANY
|
|
MERCK KGAA, DARMSTADT, GERMANY
|
|
Date:
|
January
20, 2020
|
|
Date:
|
January
20, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andreas Stickler
|
|
By:
|
/s/ Tobias Greven
|
|
|
|
|
|
|
|
Name:
|
Andreas Stickler
|
|
Name:
|
Tobias Greven
|
|
|
|
|
|
|
|
Title:
|
Head of Controlling Healthcare
|
|
Title:
|
Head of Group Legal Services
|
|
EXHIBIT INDEX
Exhibit 99.1 Joint Filing
Agreement, dated January 7, 2019, by and between Ares Trading SA, Merck Serono SA, Coinsins, Switzerland, and Merck KGaA, Darmstadt,
Germany.
Intrexon (NASDAQ:XON)
Historical Stock Chart
From Jun 2024 to Jul 2024
Intrexon (NASDAQ:XON)
Historical Stock Chart
From Jul 2023 to Jul 2024